RKLB is trading 145.8% above its estimated fair value, a level that flags significant overvaluation risk.
RKLB fair value assessment
RKLB is trading 145.8% above its estimated fair value, a level that flags significant overvaluation risk.
Reality vs. Belief
RKLB's price is driven mostly by belief and is detached from its underlying fundamentals.
RKLB signal snapshot
RKLB projected price & trade signal
What's driving RKLB's price
The story driving RKLB right now: Rocket Lab stock is rising due to a record Electron launch deal and a buy rating from Citi. High volatility-momentum readings (90) indicate significant narrative-driven price displacement.
Market Prism's verdict on RKLB
Market Prism flags RKLB as Narrative Risk — the supporting story has structural weak points that raise the odds of a sharp repricing. Narrative energy has declined to 7%, suggesting the thesis is losing traction.
Valuation outlook for RKLB
Elevated narrative risk means the move is fragile. Watch for the first crack in the story — these names tend to reprice faster than the fundamentals change. The 145.8% fair-value deviation is extreme and, historically, tends to revert within 30–60 trading days.
Frequently asked questions
Is RKLB overvalued right now?
RKLB is trading 145.8% above its estimated fair value, a level that flags significant overvaluation risk.
What is Market Prism's verdict on RKLB?
Market Prism flags RKLB as Narrative Risk — the supporting story has structural weak points that raise the odds of a sharp repricing. Narrative energy has declined to 7%, suggesting the thesis is losing traction.
What happens next for RKLB?
Elevated narrative risk means the move is fragile. Watch for the first crack in the story — these names tend to reprice faster than the fundamentals change. The 145.8% fair-value deviation is extreme and, historically, tends to revert within 30–60 trading days.
Is RKLB a good value investment?
Market Prism does not provide investment recommendations. Our forensic analysis shows: RKLB is carrying elevated narrative risk, trading 145.8% above estimated fair value, with weakening narrative momentum.